About UsProductsDistributionInvestor RelationsNewsCareersContact Us
Micro Therapeutics, Inc.
Investor Relations

Investor FAQ
Q: When and where was MTI incorporated?
A: MTI was incorporated in the state of California in 1993 and reincorporated in Delaware in 1996.
Q: Where is MTI listed and what is its ticker symbol?
A: MTI is a NASDAQ listed company and trades under the symbol MTIX.
Q: When was MTI’s initial public offering (IPO)?
A: The IPO was February 17, 1997.
Q: Has MTI had any stock splits?
A: There have been no stock splits since the company went public.
Q: Does MTI have preferred stock?
A: MTI is authorized to issue up to 5,000,000 shares of Preferred Stock in one or more series and to fix the rights, preferences and privileges without stockholder approval. At December 31, 2003, no shares of preferred stock were issued or outstanding.
Q: Does MTI pay a dividend on its common stock?
A: MTI has never declared a cash dividend on its common stock and has no plans to initiate a dividend program.
Q: How many people does MTI employ?
A: At March 2, 2004, MTI had 241 employees, all of whom were employed on a full-time basis, and 38 of whom were directly employed by employment agencies. Please refer to the company’s SEC filings for any updates to these employee figures.
Q: Does MTI have a direct stock purchase program?
A: MTI does not have a direct stock purchase program for anyone other than its employees, and currently does not anticipate establishing one.
Q: When does MTI’s fiscal year end?
A: MTI’s year ends on December 31.
Q: What is MTI’s business?
A: MTI develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of vascular disorders. Its primary focus is on catheter based technologies and products for the interventional neuroradiology market.
Q: Who is MTI’s transfer agent?
A: The transfer agent is U.S. Stock Transfer. The mailing address is 1745 Gardena Avenue, Suite 200, Glendale CA 91204. The telephone number is 818-502-1404.
Q: Who audits MTI’s financial statements?
A: The independent accounting firm that audits MTI’s financial statements is PricewaterhouseCoopers LLP.
Q: Who is MTI’s outside legal counsel?
A: Stradling Yocca Carlson & Rauth is MTI’s outside legal counsel.
Q: What is MTI’s CUSIP number?
A: The CUSIP number is 59500W100. The acronym stands for Committee on Uniform Securities Identification Procedures.



HomeSite Credit